Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

51.18EUR
15 Aug 2014
Price Change (% chg)

€-0.64 (-1.24%)
Prev Close
€51.82
Open
€51.77
Day's High
€52.36
Day's Low
€51.12
Volume
1,025,801
Avg. Vol
858,191
52-wk High
€58.26
52-wk Low
€46.69

FMEG.DE

Chart for FMEG.DE

About

Fresenius Medical Care AG & Co KGaA is a Germany-based kidney dialysis company that operates in the fields of dialysis care and dialysis products for the treatment of end-stage renal disease (ESRD). Its dialysis business is vertically integrated and offers products and services for the entire dialysis value chain, providing... (more)

Overall

Beta: 0.21
Market Cap (Mil.): €18,016.82
Shares Outstanding (Mil.): 310.70
Dividend: 0.77
Yield (%): 1.34

Financials

  FMEG.DE Industry Sector
P/E (TTM): 21.95 27.62 34.41
EPS (TTM): 2.64 -- --
ROI: 6.24 8.37 17.37
ROE: 11.17 12.88 18.18
Search Stocks

Fresenius sells $900 mln in bonds to fund acquisitions, business

FRANKFURT, Oct 24 - Fresenius Medical Care on Friday said it placed bonds worth $900 million to fund potential acquisitions, pay down debt and to invest in its business.

24 Oct 2014

FMC buys National Cardiovascular Partners in services expansion

FRANKFURT, Oct 22 - Germany's Fresenius Medical Care (FMC) has agreed to buy National Cardiovascular Partners (NCP) to expand the range of services it offers linked to its core business of kidney dialysis.

22 Oct 2014

BRIEF-FMC says places equity-neutral convertible bonds worth 400 mln eur

Sept 16 - Fresenius Medical Care : * Says places equity-neutral convertible bonds * Says says placed equity-neutral convertible 1 bonds in an aggregate principal

16 Sep 2014

Fresenius Medical Care says to issue $518 mln convertible bonds

FRANKFURT, Sept 16 - German kidney dialysis provider Fresenius Medical Care plans to issue 400 million euros ($518 million) in convertible bonds maturing in January 2020, it said on Tuesday.

16 Sep 2014

UPDATE 2-Express Scripts drops Amgen anemia drugs from formulary

Aug 1 - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said on Friday it will remove an additional 25 products from its list of preferred drugs in 2015, including anemia drugs Epogen and Aranesp, sold by Amgen Inc.

01 Aug 2014

Express Scripts drops Amgen anemia drugs from formulary

- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen and Aranesp, both sold by Amgen Inc.

01 Aug 2014

Fresenius raises sales outlook on acquisitions

FRANKFURT, July 31 - German healthcare group Fresenius SE lifted its full-year sales outlook on Thursday to include acquisitions at its subsidiary Fresenius Medical Care.

31 Jul 2014

Deals of the day- Mergers and acquisitions

(Adds Electrica, Allergan, Audika, Daimler and others; updates Fresenius Medical Care, Borussia Dortmund)

27 Jun 2014

UPDATE 1-Germany's FMC takes $600 mln stake in Sound Physicians

* FMC seeks to expand services linked to core dialysis ops

27 Jun 2014

Fresenius Medical Care takes $600 mln stake in Sound Physicians

FRANKFURT, June 27 - Germany's Fresenius Medical Care (FMC) agreed to buy a majority stake in Sound Inpatient Physicians Inc for about $600 million, part of a drive to offer additional services linked to its core business of kidney dialysis.

27 Jun 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks